01
Sat, Oct
43 New Articles

KLC Advises Teva on Greek Manufacturing Site Divestment to PharmaPath

KLC Advises Teva on Greek Manufacturing Site Divestment to PharmaPath

Greece
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

The KLC Law Firm has advised Teva on the divestment of its Greek manufacturing site to PharmaPath.

Teva Pharmaceuticals develops and produces generic and specialty medicines with a portfolio of 3,500 products.

Founded in 2017, PharmaPath is a European pharmaceutical company located in Greece. The company specializes in the in-house development, registration, manufacturing, supply, and life-cycle management of pharmaceutical products.

KLC did not provide further information on the deal.